Description
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
Product Unit Size | Cost | Quantity | Stock |
---|
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
Cas No. | 1421373-98-9 |
---|---|
Purity | ≥98% |
Formula | C27H31N7O2 |
Formula Wt. | 485.59 |
IUPAC Name | N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-5-{[4-(1H-indol-3-yl)-2-pyrimidinyl]amino}-4-methoxyphenyl)acrylamide |
Synonym | AZ-5104, AZ 5104, AZ5104 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Yates J. Ashton S., et al. Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104. Mol Cancer Ther. 15(10):2378-87 (2016). PMID: 27439477.
RXR agonist.
Thienopyridine; P2Y12 antagonist.
Proteasome inhibitor.
Cathepsin K inhibitor.
Synthetic peptide fragment, prion protein analo...
PRMT5 inhibitor
CHK1 inhibitor.
Endogenous alkaloid also found in citrus fruits...
Microtubule polymerization inhibitor, potential...
Fluoroquinolone; topoisomerase IV, topoisomeras...
Cysteine adduct inducer, PARP-1 inhibitor.
Endogenous peptide, involved in immune signalin...
Mixture of taxanes.
Thienylbutyl ITC analog.
PKD inhibitor.
p53 inhibitor
Metabolite of spironolactone; Na+/K+ ATPase par...
Decreases expression of MMPs, PGE2, and COX-2, ...
Mycotoxin produced by Fusarium; ER agonist.
nNOS inhibitor.